Effect of 5-imino-2,2,4,4-tetrakis (trifluoromethyl) imidazolidine (EXP 338) on spasticity: A quantitative evaluation.
D002986:Clinical Trials as Topic; D004569:Electroencephalography; D004576:Electromyography; D005461:Fluorine; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy; D009132:Muscles / Q000009:adverse effects / Q000627:therapeutic use*
D007093:Imidazoles; D005461:Fluorine